Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodies.

Arthritis research & therapy·2026
Same author

Immune Checkpoint Inhibitor-Associated Uveitis Treated with the 0.19 Mg Fluocinolone Acetonide Intravitreal Implant: Clinical Outcomes in a Retrospective Case-Series.

Ocular immunology and inflammation·2026
Same author

[Inflammatory Eye Diseases].

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

TRP-Dependent Calcium Regulation in HCEC-12 Cells: Involvement of Ascorbic Acid and Cannabinoid Receptor Signaling.

International journal of molecular sciences·2026
Same author

Transcriptomic Analysis Suggests Overlapping Molecular Pathogenesis in JIA-Associated and ANA-Positive Uveitis.

Biomolecules·2026

Related Experiment Video

Updated: Feb 10, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K

[Cataracts in Uveitis].

Arnd Heiligenhaus1,2, Karoline Walscheid1, Uwe Pleyer3

  • 1Augenzentrum und Ophtha-Lab, St. Franziskus Hospital, Münster.

Klinische Monatsblatter Fur Augenheilkunde
|May 9, 2018
PubMed
Summary
This summary is machine-generated.

Cataract surgery in uveitis patients requires careful planning and management. Optimizing inflammation control before, during, and after surgery improves visual outcomes and reduces complications.

More Related Videos

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.7K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.1K

Related Experiment Videos

Last Updated: Feb 10, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.7K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.1K

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Cataracts are a common complication of uveitis, posing management challenges.
  • Understanding uveitis etiology and comorbidities is crucial for surgical planning.
  • Effective preoperative patient selection is vital for successful outcomes.

Purpose of the Study:

  • To outline strategies for optimizing cataract surgery in uveitis patients.
  • To highlight the importance of inflammation control for surgical success.

Main Methods:

  • Preoperative assessment of uveitis activity and comorbidities.
  • Use of steroid-sparing disease-modifying antirheumatic drugs (DMARDs).
  • Minimally invasive surgical techniques and intraocular corticosteroid use.
  • Intensified postoperative anti-inflammatory medication regimen.

Main Results:

  • Achieving stable intraocular inflammation control preoperatively is essential.
  • Minimally invasive surgery and intraocular corticosteroids can reduce complications.
  • Postoperative anti-inflammatory management up to 3 months aids recovery.

Conclusions:

  • Careful patient selection, surgical planning, and execution are key.
  • Optimized perioperative management leads to satisfactory anatomical and functional results in uveitis patients undergoing cataract surgery.